Aveanna Healthcare (AVAH) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Management team and governance
President and CEO is Jeff Shaner, who also serves as a director.
Matthew Buckhalter is the Chief Financial Officer.
Deborah Stewart is Senior Vice President and Chief Accounting Officer.
Board includes Rodney D. Windley (Chairman), Victor F. Ganzi, Christopher R. Gordon, Devin O'Reilly, Sheldon M. Retchin, Steven E. Rodgers, Erica Schwartz, and Robert M. Williams, Jr.
Directors and officers are indemnified to the fullest extent permitted by Delaware law, with additional indemnification agreements and D&O insurance in place.
Offering details and pricing
Registration statement filed on Form S-3 for a shelf offering, allowing securities to be sold from time to time as determined by market conditions.
$101,942 listed as the SEC registration fee; other offering expenses to be provided by amendment.
Includes forms for various securities: senior and subordinated notes, warrants, subscription rights, and units.
Underwriters and syndicate
Form of Underwriting Agreement included as an exhibit; specific underwriters not named in the filing.
Latest events from Aveanna Healthcare
- Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - Accelerating growth via preferred payer strategy, targeting $200M EBITDA by 2026.AVAH
Jefferies Global Healthcare Conference1 Feb 2026 - 2025 guidance raised as transformation and Q3 results drive scalable, value-based growth.AVAH
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Q3 revenue up 6.5%, adjusted EBITDA rose 32.2%, and guidance was raised for 2024.AVAH
Q3 202416 Jan 2026 - Strategic transformation and efficiency drive growth, margin expansion, and strong cash flow.AVAH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026 - Strong 2024 revenue and margin gains, with 2025 guidance signaling further growth.AVAH
Q4 202424 Dec 2025 - Registering $400M in securities and 54M+ shares for resale, targeting home care growth.AVAH
Registration Filing16 Dec 2025 - Double-digit growth driven by scale, payer partnerships, and disciplined expansion.AVAH
Bank of America Home Care Conference9 Dec 2025